Click for best price
Gastric Motility Disorder Drug Market Size, Share 2022
This report contains market size and forecasts of Gastric Motility Disorder Drug in global, including the following market information:
Global Gastric Motility Disorder Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastric Motility Disorder Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Gastric Motility Disorder Drug companies in 2021 (%)
The global Gastric Motility Disorder Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Velusetrag Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastric Motility Disorder Drug include Theravance, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc., Targacept, Inc. and ChironWells GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastric Motility Disorder Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Motility Disorder Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, by Type, 2021 (%)
Velusetrag
Ipamorelin
TD-8954
Others
Global Gastric Motility Disorder Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Use
Global Gastric Motility Disorder Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Motility Disorder Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastric Motility Disorder Drug revenues share in global market, 2021 (%)
Key companies Gastric Motility Disorder Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Gastric Motility Disorder Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Theravance, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
Targacept, Inc.
ChironWells GmbH
| Report Attributes |
Report Details |
| Report Title |
Gastric Motility Disorder Drug Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastric Motility Disorder Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Motility Disorder Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Motility Disorder Drug Overall Market Size
2.1 Global Gastric Motility Disorder Drug Market Size: 2021 VS 2028
2.2 Global Gastric Motility Disorder Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastric Motility Disorder Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Gastric Motility Disorder Drug Players in Global Market
3.2 Top Global Gastric Motility Disorder Drug Companies Ranked by Revenue
3.3 Global Gastric Motility Disorder Drug Revenue by Companies
3.4 Global Gastric Motility Disorder Drug Sales by Companies
3.5 Global Gastric Motility Disorder Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastric Motility Disorder Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastric Motility Disorder Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Motility Disorder Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastric Motility Disorder Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Motility Disorder Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastric Motility Disorder Drug Market Size Markets, 2021 & 2028
4.1.2 Velusetrag
4.1.3 Ipamorelin
4.1.4 TD-8954
4.1.5 Others
4.2 By Type - Global Gastric Motility Disorder Drug Revenue & Forecasts
4.2.1 By Type - Global Gastric Motility Disorder Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastric Motility Disorder Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastric Motility Disorder Drug Sales & Forecasts
4.3.1 By Type - Global Gastric Motility Disorder Drug Sales, 2017-2022
4.3.2 By Type - Global Gastric Motility Disorder Drug Sales, 2023-2028
4.3.3 By Type - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastric Motility Disorder Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Gastric Motility Disorder Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Use
5.2 By Application - Global Gastric Motility Disorder Drug Revenue & Forecasts
5.2.1 By Application - Global Gastric Motility Disorder Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastric Motility Disorder Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastric Motility Disorder Drug Sales & Forecasts
5.3.1 By Application - Global Gastric Motility Disorder Drug Sales, 2017-2022
5.3.2 By Application - Global Gastric Motility Disorder Drug Sales, 2023-2028
5.3.3 By Application - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastric Motility Disorder Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Gastric Motility Disorder Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastric Motility Disorder Drug Revenue & Forecasts
6.2.1 By Region - Global Gastric Motility Disorder Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastric Motility Disorder Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastric Motility Disorder Drug Sales & Forecasts
6.3.1 By Region - Global Gastric Motility Disorder Drug Sales, 2017-2022
6.3.2 By Region - Global Gastric Motility Disorder Drug Sales, 2023-2028
6.3.3 By Region - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastric Motility Disorder Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastric Motility Disorder Drug Sales, 2017-2028
6.4.3 US Gastric Motility Disorder Drug Market Size, 2017-2028
6.4.4 Canada Gastric Motility Disorder Drug Market Size, 2017-2028
6.4.5 Mexico Gastric Motility Disorder Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastric Motility Disorder Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastric Motility Disorder Drug Sales, 2017-2028
6.5.3 Germany Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.4 France Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.5 U.K. Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.6 Italy Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.7 Russia Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.9 Benelux Gastric Motility Disorder Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastric Motility Disorder Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastric Motility Disorder Drug Sales, 2017-2028
6.6.3 China Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.4 Japan Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.5 South Korea Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.7 India Gastric Motility Disorder Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastric Motility Disorder Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastric Motility Disorder Drug Sales, 2017-2028
6.7.3 Brazil Gastric Motility Disorder Drug Market Size, 2017-2028
6.7.4 Argentina Gastric Motility Disorder Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastric Motility Disorder Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastric Motility Disorder Drug Sales, 2017-2028
6.8.3 Turkey Gastric Motility Disorder Drug Market Size, 2017-2028
6.8.4 Israel Gastric Motility Disorder Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastric Motility Disorder Drug Market Size, 2017-2028
6.8.6 UAE Gastric Motility Disorder Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Theravance, Inc.
7.1.1 Theravance, Inc. Corporate Summary
7.1.2 Theravance, Inc. Business Overview
7.1.3 Theravance, Inc. Gastric Motility Disorder Drug Major Product Offerings
7.1.4 Theravance, Inc. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.1.5 Theravance, Inc. Key News
7.2 Helsinn Healthcare S.A.
7.2.1 Helsinn Healthcare S.A. Corporate Summary
7.2.2 Helsinn Healthcare S.A. Business Overview
7.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Major Product Offerings
7.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.2.5 Helsinn Healthcare S.A. Key News
7.3 Concert Pharmaceuticals, Inc.
7.3.1 Concert Pharmaceuticals, Inc. Corporate Summary
7.3.2 Concert Pharmaceuticals, Inc. Business Overview
7.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Major Product Offerings
7.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.3.5 Concert Pharmaceuticals, Inc. Key News
7.4 Targacept, Inc.
7.4.1 Targacept, Inc. Corporate Summary
7.4.2 Targacept, Inc. Business Overview
7.4.3 Targacept, Inc. Gastric Motility Disorder Drug Major Product Offerings
7.4.4 Targacept, Inc. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.4.5 Targacept, Inc. Key News
7.5 ChironWells GmbH
7.5.1 ChironWells GmbH Corporate Summary
7.5.2 ChironWells GmbH Business Overview
7.5.3 ChironWells GmbH Gastric Motility Disorder Drug Major Product Offerings
7.5.4 ChironWells GmbH Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.5.5 ChironWells GmbH Key News
8 Global Gastric Motility Disorder Drug Production Capacity, Analysis
8.1 Global Gastric Motility Disorder Drug Production Capacity, 2017-2028
8.2 Gastric Motility Disorder Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Motility Disorder Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Motility Disorder Drug Supply Chain Analysis
10.1 Gastric Motility Disorder Drug Industry Value Chain
10.2 Gastric Motility Disorder Drug Upstream Market
10.3 Gastric Motility Disorder Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Motility Disorder Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastric Motility Disorder Drug in Global Market
Table 2. Top Gastric Motility Disorder Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gastric Motility Disorder Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gastric Motility Disorder Drug Revenue Share by Companies, 2017-2022
Table 5. Global Gastric Motility Disorder Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Gastric Motility Disorder Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gastric Motility Disorder Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Gastric Motility Disorder Drug Product Type
Table 9. List of Global Tier 1 Gastric Motility Disorder Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastric Motility Disorder Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Gastric Motility Disorder Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gastric Motility Disorder Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gastric Motility Disorder Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gastric Motility Disorder Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Gastric Motility Disorder Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Gastric Motility Disorder Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gastric Motility Disorder Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gastric Motility Disorder Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gastric Motility Disorder Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Gastric Motility Disorder Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Gastric Motility Disorder Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gastric Motility Disorder Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gastric Motility Disorder Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gastric Motility Disorder Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Gastric Motility Disorder Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gastric Motility Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gastric Motility Disorder Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Gastric Motility Disorder Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gastric Motility Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gastric Motility Disorder Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Gastric Motility Disorder Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gastric Motility Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gastric Motility Disorder Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Gastric Motility Disorder Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gastric Motility Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gastric Motility Disorder Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Gastric Motility Disorder Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gastric Motility Disorder Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gastric Motility Disorder Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Gastric Motility Disorder Drug Sales, (K Pcs), 2023-2028
Table 46. Theravance, Inc. Corporate Summary
Table 47. Theravance, Inc. Gastric Motility Disorder Drug Product Offerings
Table 48. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Helsinn Healthcare S.A. Corporate Summary
Table 50. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Offerings
Table 51. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Concert Pharmaceuticals, Inc. Corporate Summary
Table 53. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Offerings
Table 54. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Targacept, Inc. Corporate Summary
Table 56. Targacept, Inc. Gastric Motility Disorder Drug Product Offerings
Table 57. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. ChironWells GmbH Corporate Summary
Table 59. ChironWells GmbH Gastric Motility Disorder Drug Product Offerings
Table 60. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Gastric Motility Disorder Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 62. Global Gastric Motility Disorder Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Gastric Motility Disorder Drug Production by Region, 2017-2022 (K Pcs)
Table 64. Global Gastric Motility Disorder Drug Production by Region, 2023-2028 (K Pcs)
Table 65. Gastric Motility Disorder Drug Market Opportunities & Trends in Global Market
Table 66. Gastric Motility Disorder Drug Market Drivers in Global Market
Table 67. Gastric Motility Disorder Drug Market Restraints in Global Market
Table 68. Gastric Motility Disorder Drug Raw Materials
Table 69. Gastric Motility Disorder Drug Raw Materials Suppliers in Global Market
Table 70. Typical Gastric Motility Disorder Drug Downstream
Table 71. Gastric Motility Disorder Drug Downstream Clients in Global Market
Table 72. Gastric Motility Disorder Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastric Motility Disorder Drug Segment by Type
Figure 2. Gastric Motility Disorder Drug Segment by Application
Figure 3. Global Gastric Motility Disorder Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gastric Motility Disorder Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastric Motility Disorder Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Gastric Motility Disorder Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Gastric Motility Disorder Drug Revenue in 2021
Figure 9. By Type - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gastric Motility Disorder Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gastric Motility Disorder Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 19. US Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 24. Germany Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 33. China Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 40. Brazil Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gastric Motility Disorder Drug Sales Market Share, 2017-2028
Figure 44. Turkey Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gastric Motility Disorder Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gastric Motility Disorder Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Gastric Motility Disorder Drug by Region, 2021 VS 2028
Figure 50. Gastric Motility Disorder Drug Industry Value Chain
Figure 51. Marketing Channels
